Seven Mile Advisory’s AbbVie ABBV Stock Holding History

Seven Mile Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$489K	Sell	1,870 -71	-4%	-$18.2K	0.33%	60
2026 Q2	$488K	Sell	1,941 -367	-16%	-$79K	0.33%	64
2026 Q1	$502K	Sell	2,308 -1,158	-33%	-$257K	0.36%	56
2025 Q4	$792K	Sell	3,466 -2,179	-39%	-$496K	0.14%	81
2025 Q3	$1.31M	Buy	5,645 +2,363	+72%	+$481K	0.21%	69
2025 Q2	$609K	Buy	3,282 +266	+9%	+$49.4K	0.37%	47
2025 Q1	$632K	Buy	3,016 +239	+9%	+$46.5K	0.42%	41
2024 Q4	$493K	Buy	2,777 +102	+4%	+$18.8K	0.31%	59
2024 Q3	$528K	Buy	2,675 +522	+24%	+$97.4K	0.35%	55
2024 Q2	$369K	Buy	2,153 +41	+2%	+$6.79K	0.27%	75
2024 Q1	$385K	Buy	2,112 +115	+6%	+$19.8K	0.29%	72
2023 Q4	$309K	Sell	1,997 -79	-4%	-$11.5K	0.27%	84
2023 Q3	$309K	Buy	2,076 +354	+21%	+$52K	0.33%	74
2023 Q2	$232K	Buy	+1,722	New	+$253K	0.27%	91

Other funds holding ABBV

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Seven Mile Advisory's ABBV Position: Q3 2026 in Review

Seven Mile Advisory reduced its AbbVie (ABBV) stake by 3.7% in Q3 2026, selling an estimated $18.2K and leaving 1,870 shares worth $489K. The position accounts for 0.33% of the portfolio, ranked #60.

Seven Mile Advisory first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.31M in Q3 2025. 3,500 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Seven Mile Advisory held 1,870 shares of AbbVie worth $489K as of Q3 2026.
Seven Mile Advisory sold 71 AbbVie shares in Q3 2026, an estimated $18.2K.
AbbVie made up 0.33% of Seven Mile Advisory's portfolio in Q3 2026, its #60 holding.
Seven Mile Advisory first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
Seven Mile Advisory's AbbVie position peaked at $1.31M in Q3 2025.
3,500 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Seven Mile Advisory's 13F filing for Q3 2026, filed 22 Oct 2026.